Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma

NCT04659811 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Grade I Meningioma, Adult
Grade II Meningioma, Adult
Grade III Meningioma, Adult
Recurrent Meningioma

Interventions

DRUG: Pembrolizumab
PROCEDURE: Stereotactic Radiosurgery

Sponsor

Nancy Ann Oberheim Bush, MD

Collaborators

[object Object]